Synthesis, characterization and evaluation of 1,3,5-triazine aminobenzoic acid derivatives for their antimicrobial activity

Abstract

Background

Replacement of chloride ions in cyanuric chloride give several variants of 1,3,5-triazine derivatives which were investigated as biologically active small molecules. These compounds exhibit antimalarial, antimicrobial, anti-cancer and anti-viral activities, among other beneficial properties. On the other hand, treatment of bacterial infections remains a challenging therapeutic problem because of the emerging infectious diseases and the increasing number of multidrug-resistant microbial pathogens. As multidrug-resistant bacterial strains proliferate, the necessity for effective therapy has stimulated research into the design and synthesis of novel antimicrobial molecules.

Results

1,3,5-Triazine 4-aminobenzoic acid derivatives were prepared by conventional method or by using microwave irradiation. Using microwave irradiation gave the desired products in less time, good yield and higher purity. Esterification of the 4-aminobenzoic acid moiety afforded methyl ester analogues. The s-triazine derivatives and their methyl ester analogues were fully characterized by FT-IR, NMR (¹H-NMR and ¹³C-NMR), mass spectra and elemental analysis. All the synthesized compounds were evaluated for their antimicrobial activity. Some tested compounds showed promising activity against Staphylococcus aureus and Escherichia coli.

Conclusions

Three series of mono-, di- and trisubstituted s-triazine derivatives and their methyl ester analogues were synthesized and fully characterized. All the synthesized compounds were evaluated for their antimicrobial activity. Compounds (10), (16), (25) and (30) have antimicrobial activity against S. aureus comparable to that of ampicillin, while the activity of compound (13) is about 50% of that of ampicillin. Compounds (13) and (14) have antimicrobial activity against E. coli comparable to that of ampicillin, while the activity of compounds (9–12) and (15) is about 50% of that of ampicillin. Furthermore, minimum inhibitory concentrations values for clinical isolates of compounds (10), (13), (14), (16), (25) and (30) were measured. Compounds (10) and (13) were more active against MRSA and E. coli than ampicillin. Invitro cytotoxicity results revealed that compounds (10) and (13) were nontoxic up to 250 µg/mL (with SI = 10) and 125 µg/mL (with SI = 5), respectively.

Graphical abstract.

Three series of mono-, di- and trisubstituted s-triazine derivatives and their methyl ester analogues were synthesized and evaluated for their antimicrobial activity. Several compounds have antimicrobial activity against S. aureus and E. coli comparable to that of ampicillin.

Electronic supplementary material

The online version of this article (doi:10.1186/s13065-017-0267-3) contains supplementary material, which is available to authorized users.

Background

Sophisticated s-triazine derivatives can be easily prepared from the cheap and readily available 2,4,6-trichloro-1,3,5-triazine (cyanuric chloride) 1 [1–3]. Replacement of chloride ions in cyanuric chloride give several variants of 1,3,5-triazine derivatives, which were investigated as biologically active small molecules [4–8]. These compounds exhibit antimalarial [9–16], antimicrobial [17–25], anti-cancer [26–31] and anti-viral activities [32], among other beneficial properties. On the other hand, treatment of bacterial infections remains a challenging therapeutic problem because of emerging infectious diseases and the increasing number of multidrug-resistant microbial pathogens [33]. As multidrug-resistant bacterial strains proliferate, the necessity for effective therapy has stimulated research into the design and synthesis of novel antimicrobial molecules [34–42].

In this study, we prepared several 1,3,5-triazine derivatives by replacing one, two, or three chloride ions of cyanuric chloride with different N-nucleophiles (including 4-aminobenzoic acid, methyl p-aminobenzoate, aniline, benzylamine, diethylamine, morpholine and piperidine) and evaluated their antimicrobial activity.

Results and discussion

Chemistry

Cyanuric chloride (1) is definitely an excellent starting compound for the straight forward preparation of highly structured multitopic molecules [1]. The first substitution is exothermic; therefore, the temperature of the reaction mixture has to be maintained at 0 °C. The substitution of the second chloride can be performed at room temperature. Finally, the third position is functionalized under reflux of the solvent. As a result, a careful control of the reaction temperature during the substitution reactions will allow the synthesis of 2,4,6-trisubstituted-1,3,5-triazines by the sequential and very selective addition of amine nucleophiles [1, 43].

A monosubstituted 1,3,5-triazine series was prepared selectively by substituting one chloride ion of cyanuric chloride (1) with 4-aminobenzoic acid (2), aniline, benzylamine, diethylamine, morpholine or piperidine in the presence of sodium carbonate as an acid scavenger of the liberated hydrochloric acid, in an ice-bath, to afford products 4-((4,6-dichloro-1,3,5-triazin-2yl)amino)benzoic acid (3), 4,6-dichloro-N-phenyl-1,3,5-triazin-2-amine (4), N-benzyl-4,6-dichloro-1,3,5-triazin-2-amine (5), 4,6-dichloro-N,N-diethyl-1,3,5-triazin-2-amine (6), 4-(4,6-dichloro-1,3,5-triazin-2-yl)morpholine (7), and 2,4-dichloro-6-(piperidin-1-yl)-1,3,5-triazine (8), respectively (Scheme 1). The structure of the products was confirmed using NMR (¹H and ¹³C), IR and elemental analysis.

Scheme 1.

Synthesis of mono-, di- and trisubstituteds-triazine derivatives 3 – 18

In addition, a series of disubstituted 1,3,5-triazine was prepared by replacement of the second chloride ion of 4-((4,6-dichloro-1,3,5-triazin-2-yl)amino)benzoic acid (3) with aniline, benzylamine, diethylamine, morpholine, or piperidine, respectively. The reaction mixture was stirred overnight at room temperature in presence of sodium carbonate to give 4-((4-chloro-6-(phenylamino)-1,3,5-triazin-2-yl)amino)benzoic acid (9), 4-((4-(benzylamino)-6-chloro-1,3,5-triazin-2-yl)amino)benzoic acid (10), 4-((4-chloro-6-(diethylamino)-1,3,5-triazin-2-yl)amino)benzoic acid (11), 4-((4-chloro-6-morpholino-1,3,5-triazin-2-yl)amino)benzoic acid (12), and 4-((4-chloro-6-(piperidin-1-yl)-1,3,5-triazin-2-yl)amino)benzoic acid (13), respectively (Scheme 1). The structure of the products was confirmed using NMR (¹H and ¹³C), IR, mass spectra and elemental analysis.

The ¹H-NMR of compound (11) in DMSO-d ₆ showed that the two ethyl groups of the diethylamino moiety are not equivalent, as indicated from their chemical shift values, where the two methyl groups are observed at 1.09 and 1.15 ppm as two triplets and the methylene groups are observed at the range 3.50–3.53 ppm as a multiplet. These observations indicate that the two ethyl groups are found in different electronic environments. This fact can be attributed to restricted rotation around the C₆–N bond due to resonance that gives this bond some double bond character [44]. The difference in the chemical shifts of ethyl groups are probably due to differences in the field effects (anisotropic effects) of the benzoyl group of 4-aminobenzoic acid substituents on C₂ on either ethyl groups (Fig. 1). The aromatic protons appear as two doublets at chemical shifts 7.79 and 7.86 ppm. The two D₂O exchangeable protons (NH and OH) are observed at 10.34 and 12.69 ppm, respectively. The previous prediction was confirmed by the ¹³C-NMR spectrum of compound (11), where the two methyl carbons appear as two peaks at 13.01 and 13.47 ppm and the two methylene carbons are observed at 42.01 and 42.47 ppm.

Fig. 1.

Restricted rotation around C₆–N bond due to resonance

Furthermore, C₂-symmetrical 1,3,5-triazine tripod series were prepared by replacing the two chloride ions of 4-((4,6-dichloro-1,3,5-triazin-2-yl)amino)benzoic acid (3) with two equivalents of aniline, benzylamine, diethylamine, morpholine, or piperidine, respectively. The reaction proceeded at 70–80 °C in dioxane/water solvent mixture using sodium carbonate as a base by the conventional method; or by using microwave irradiation and employing a multimode reactor (Synthos 3000, Aton Paar GmbH, 1400 W maximum magnetron) to produce the corresponding products: 4-((4,6-bis(phenylamino)-1,3,5-triazin-2-yl)amino)benzoic acid (14), 4-((4,6-bis(benzylamino)-1,3,5-triazin-2-yl)amino)benzoic acid (15), 4-((4,6-bis(diethylamino)-1,3,5-triazin-2-yl)amino)benzoic acid (16), 4-((4,6-dimorpholino-1,3,5-triazin-2-yl)amino)benzoic acid (17), 4-((4,6-di(piperidin-1-yl)-1,3,5-triazin-2-yl)amino)benzoic acid (18), respectively (Scheme 1). Using microwave irradiation produced the desired products in less time, good yield and higher purity. The structures of the products were confirmed using NMR (¹H and ¹³C), IR, mass spectra and elemental analysis. As a prototype of this series, in the ¹H-NMR of compound 17, the methylene group protons of morpholine moiety appear as multiplet at the chemical shift range of 3.60–3.69 ppm, and the p-disubstituted benzene ring protons appear as two doublets at chemical shifts 7.73 and 7.83 ppm. The N–H proton appears at the chemical shift range of 9.74–9.87 ppm as a broad D₂O exchangeable peak.

Similarly, another tripod series of 1,3,5-triazine derivatives (19–22) was synthesized, which differed only in one position of the triazine nucleus, but contained 4-aminobenzoic acid and morpholino moieties in all members of this series. Chloride ion of compounds (9–11) and (13) was replaced with one equivalent of morpholine at 70–80 °C in a dioxane/water solvent mixture using sodium carbonate as a base by the conventional method, or by using microwave irradiation, employing a multimode reactor (Synthos 3000, Aton Paar GmbH, 1400 W maximum magnetron) to give the corresponding products (Scheme 2). Using microwave irradiation produced the desired products in less time, good yield and higher purity. The structures of the products were confirmed using NMR (¹H and ¹³C), IR and elemental analyses. As a prototype of this series, in the ¹H-NMR of compound (20), the eight methylene protons of morpholine appear as multiplet at a chemical shift range of 3.57–3.74 ppm, while the benzyl methylene group protons appear as multiplet at 4.45–4.50 ppm. The nine aromatic protons appear as multiplet at chemical shift ranges of 7.18–7.71 and 7.69–7.85 ppm. The N–H proton (D₂O exchangeable) appears as multiplet at 9.49–9.73 ppm due to its coupling with the adjacent methylene protons. The O–H proton (D₂O exchangeable) is observed at 12.40 ppm as a singlet peak. The multiplet appearance of benzyl methylene protons indicates that the two protons are not equivalent (enantiotopic protons). From the conformational point of view, using the Newman projection formula (Fig. 2), H_a and H_b are not equivalent due to restricted rotation around the C₄–N bond (Fig. 1); as a result, they can couple via germinal coupling depending on the H_aCH_b angle in addition to their vicinal coupling of the NH_c proton, as shown by the staggered conformation of (20) (Fig. 2). This behavior also explains the multiplet appearance of the N–H_c proton.

Scheme 2.

Synthesis of tripod morpholino-s-triazine derivatives 19–22

Fig. 2.

Newman projection formula of N-(4-benzylamino-6-morpholino-1,3,5-triazin-2-yl) aminobenzoic acid 20

Furthermore, esterification of the previously prepared compounds (14–22) afforded compounds (23–31) (Scheme 3). The structure of the products was confirmed using NMR (¹H and ¹³C), IR, mass spectra and elemental analysis.

Scheme 3.

Synthesis of methyl ester of C₂—symmetrical and morpholino 1,3,5-triazine tripod derivatives 23–31

Antimicrobial activity

The synthesized compounds (9–31) have been evaluated for their antimicrobial activity against E. coli representing Gram-negative bacteria, S. aureus representing Gram-positive bacteria and C. albicans representing fungi. Microdilution susceptibility test in Müller–Hinton Broth (Oxoid) and Sabouraud Liquid Medium (Oxoid) were used for the determination of antibacterial and antifungal activity [45]. The minimal inhibitory concentration (MIC) values listed in Table 1 showed that all tested compounds have lower antifungal activity than clotrimazole (Canesten^®, Bayer).

Table 1.

Minimal inhibitory concentration (MIC) of test compounds in μg/mL

Test compound	E. coli	S. aureus	C. albicans	Test compound	E. coli	S. aureus	C. albicans
Ampicillin	25	12.5	–	20	100	>200	>200
Clotrimazole	–	–	12.5	21	100	50	>200
9	50	100	>200	22	100	100	>200
10	50	12.5	>200	23	100	100	>200
11	50	100	>200	24	100	100	>200
12	50	50	>200	25	100	12.5	>200
13	25	25	>200	26	100	100	>200
14	25	100	>200	27	100	100	>200
15	50	>200	>200	28	100	>200	>200
16	100	12.5	>200	29	100	>200	>200
17	100	100	>200	30	100	12.5	>200
18	100	>200	>200	31	100	100	>200
19	>200	100	>200

The synthesized compounds are more active against S. aureus and E. coli. Compounds (10), (16), (25) and (30) have antimicrobial activity against S. aureus comparable to that of ampicillin, while the activity of compound (13) is about 50% of that of ampicillin. Compounds (13) and (14) have antimicrobial activity against E. coli comparable to that of ampicillin, while the activity of compounds (9–12) and (15) is about 50% of that of ampicillin.

Furthermore, minimum inhibitory concentrations (MIC µg/mL) values for clinical isolates of compounds (10), (13), (14), (16), (25) and (30) were also tested and listed in Table 2. Compounds (10) and (13) were more active against MRSA and E. coli than ampicillin.

Table 2.

Minimum inhibitory concentrations (MIC µg/mL) for clinical isolates of compounds (10), (13), (14), (16), (25) and (30)

Test compound	MRSA	E. coli
Ampicillin	>200	>200
10	25	100
13	100	25
14	>200	100
16	100	>200
25	100	100
30	>200	>200

MRSA methicillin-resistant Staphylococcus aureus

Invitro cytotoxicity of the most active compounds (10) and (13) were carried out with 5ero cell line using Mosmann method with certain modifications as described in the literature [46]. 50% cytotoxic concentration (CC₅₀) expressed in µg/mL and selectivity index (SI) values were listed in Table 3. The results revealed that the test compounds (10) and (13) were nontoxic up to 250 µg/mL (with SI = 10) and 125 µg/mL (with SI = 5), respectively.

Table 3.

CC₅₀ values and selectivity index (SI) of the most active compounds on normal VERO

Test compound	(CC50)a (µg/mL)	Selectivity index (SI)b
10	250	10
13	125	5

^aCC₅₀ is the concentration of compound required to kill 50% of the fibroblast cells

^bThe selectivity index (SI) was calculated using the formula, SI = CC₅₀/MIC

Experimental section

Chemistry

Solvents and reagents were purchased from Sigma-Aldrich. Unless otherwise stated, the normal workup from organic solvent involved drying over Na₂SO₄ and rotary evaporation. TLC was performed using aluminum-backed Merck Silica Gel 60 F-254 plates using suitable solvent systems with spots being visualized by a Spectroline UV Lamp (254 or 365 nm) or I₂ vapor. Melting points were obtained in open capillary tubes using a MEL-Temp II melting point apparatus and are uncorrected. Microwave experiments were performed using a multimode reactor (Synthos 3000, Aton Paar GmbH, 1400 W maximum magnetron). Infrared spectra (IR) were recorded on a Perkin-Elmer 1600 series Fourier transform instrument as KBr pellets. The absorption bands (max) are given in wave numbers (cm⁻¹). Nuclear magnetic resonance (NMR) spectra (¹H-NMR and ¹³C-NMR) were recorded on a JEOL 500 MHz spectrometer at ambient temperature. Chemical shifts are reported in parts per million (ppm) and are referenced relative to residual solvent (e.g. CHCl₃ at δH 7.26 ppm for CDCl₃, DMSO at δH 2.50 ppm for DMSO-d₆). Spin multiplicities are represented by the following signals: singlet (s), broad singlet (br s), doublet (d), doublet of doublets (dd), triplet (t), doublet of triplets (dt), quartet (q), sextet (sex) and multiplet (m). Elemental analyses were performed on a Perkin-Elmer 2400 elemental analyzer, and the values found were within ±0.3% of the theoretical values. Mass spectra (MS) were recorded on a QP 1000EX/MS Shimatzu Corp by using electron impact (EI) at 70 eV. The antimicrobial activity and invitro cytotoxicity were carried at the lab of Prof. Adnan Bekhit, Faculty of Pharmacy, Alexandria University.

General procedure for the synthesis of 2-substituted-4,6-dichloro-1,3,5-triazine derivatives (3–8)

To a solution of cyanuric chloride (1.01 g, 5.5 mmol) in methylene chloride (10 mL), amine (5 mmol) and sodium carbonate (1.06 g, 10 mmol) were added. The mixture was vigorously stirred at 0–5 °C for 3 h. The precipitate was filtered and washed with methylene chloride. The precipitate was dissolved in small amount of water. The solution was neutralized with 1 N HCl, and the formed precipitate was filtered (Additional file 1).

N-(4,6-dichloro-1,3,5-triazin-2-yl)aminobenzoic acid (3)

The product was obtained as white solid, 1.36 g (95.4%) yield; mp > 360 °C [Lit mp > 350 °C] [47]. ¹H-NMR (500 MHz, DMSO-d₆): δ 7.70 (d, 2H, J = 8.4 Hz, Ar–H), 7.88 (d, 2H, J = 8.4 Hz, Ar–H), 10.88 (s, 1H, NH, D₂O exchangeable).

4,6-dichloro-N-phenyl-1,3,5-triazin-2-amine (4) [48]

The product was obtained as white solid, 1.11 g (92.1%) yield; mp: 235–238 °C.

N-benzyl-4,6-dichloro-1,3,5-triazin-2-amine (5) [49]

The product was obtained as white solid, 1.16 g (90.8%) yield; mp: 232–234 (dec.) °C; IR (KBr): 3650–2700 (br, OH, acid), 3268 (NH, amine), 1686 (CO, acid) cm⁻¹; ¹H-NMR (500 MHz, DMSO-d₆): δ 4.49–4.53 (m, 2H, CH₂), 7.28–7.31 (m, 5H, Ar–H), 9.60 (t, 1H, J = 6.1 Hz, NH, D₂O exchangeable), 11.15 (s, 1H, OH, D₂O exchangeable).

4,6-dichlro-N,N-diethyl-1,3,5-triazin-2-amine (6) [50]

The product was obtained as white solid, 1.05 g (94.6%) yield; mp: 241–244 °C; ¹H-NMR (500 MHz, DMSO-d₆): δ 1.09–1.11 (m, 6H, 2CH₃), 3.51–3.55 (m, 4H, 2CH₂), 11.15 (s, 1H, OH, D₂O exchangeable).

4-(4,6-dichloro-1,3,5-triazin-2-yl)morpholine (7)

The product was obtained as white solid, 1.03 g (87.3%) yield; mp: 157–158 °C [Lit mp 154–156 °C] [16];.¹H-NMR (500 MHz, CDCl₃): δ 3.69 (t, 4H, J = 5.4 Hz, 2× CH₂N), δ 3.73 (t, 4H, J = 5.4 Hz, 2× CH₂O).

2,4-dichloro-6-(piperidin-1-yl)-1,3,5-triazine (8)

The product was obtained as white solid, 1.04 g (89.2%) yield; mp: 143–145 °C [Lit mp 176–178 °C] [16]; ¹H-NMR (500 MHz, CDCl₃): δ 1.60–1.65 (m, 4H, 2CH₂), 1.69–1.72 (m, 2H, CH₂), 3.80 (t, 4H, J = 6.1 Hz, 2CH₂–N).

General procedure for the synthesis of 4-((4-chloro-6-substituted-1,3,5-triazin-2-yl)amino)benzoic acid derivatives (9–13)

To a solution of N-(4,6-dichloro-1,3,5-triazin-2-yl)aminobenzoic acid 3 (2.0 g, 7.0 mmol) and sodium carbonate (1.78 g, 16.8 mmol) in distilled water (20 mL), a solution of amine (8.4 mmol) in dioxane (5 mL) was added while stirring. The reaction mixture was stirred overnight at room temperature. The reaction mixture was neutralized with 1 N HCl. The formed precipitate was filtered and washed with water.

4-((4-chloro-6-(phenylamino)-1,3,5-triazin-2-yl)amino)benzoic acid (9)

The product was obtained as white solid, 2.38 g (99.5%) yield; mp: 292-295 (dec.) ^oC; IR (KBr): 3700–2500 (br, OH, acid), 3278 (NH, amine), 1691 (CO, acid) cm⁻¹; ¹H-NMR (500 MHz, DMSO-d₆): δ 6.98–7.35 (m, 4H, Ar–H), 7.62–7.97 (m, 5H, Ar–H), 9.38–9.73 (m, 1H, NH, D₂O exchangeable), 10.25–10.56 (m, 1H, NH, D₂O exchangeable), 12.72 (s, 1H, OH, D₂O exchangeable); ¹³C-NMR (125 MHz, DMSO-d₆): 120.32, 121.14, 128.94, 129.15, 129.36, 130.60, 140.23, 144.96, 164.42, 164.52, 167.47, 167.68. Elemental analysis calcd. for C₁₆H₁₂ClN₅O₂: C, 56.23; H, 3.54; Cl, 10.37; N, 20.49. Found: C, 56.20; H, 3.59; Cl, 10.33; N, 20.52.

4-((4-(benzylamino)-6-chloro-1,3,5-triazin-2-yl)amino)benzoic acid (10)

The product was obtained as white solid, 2.48 g (99.6%) yield; mp: 272–275 (dec.) ^oC; IR (KBr): cm⁻¹; ¹H-NMR (500 MHz, DMSO-d₆): δ 4.48–4.52 (m, 2H, CH₂), 7.20–7.31 (m, 4H, Ar–H), 7.76–7.84 (m, 5H, Ar–H), 8.70–8.83 (m, 1H, NH, D₂O exchangeable), 10.31–10.35 (m, 1H, NH, D₂O exchangeable), 12.61 (s, 1H, OH, D₂O exchangeable); ¹³C-NMR (125 MHz, DMSO-d₆): 44.2, 119.69, 125.01, 127.31, 127.87, 128.94, 130.62, 166.00, 166.18, 167.51, 168.60. Elemental analysis calcd. for C₁₇H₁₄ClN₅O₂:C, 57.39; H, 3.97; Cl, 9.96; N, 19.68. Found: C, 57.29; H, 4.03; Cl, 9.98; N, 19.64.

4-((4-chloro-6-(diethylamino)-1,3,5-triazin-2-yl)amino)benzoic acid (11)

The product was obtained as white solid, 2.04 g (90.6%) yield; mp: 220–222 (dec.) ^oC; IR (KBr): 3700–2500 (br, OH, acid), 3285 (NH, amine), 1689 (CO, acid) cm⁻¹; ¹H-NMR (500 MHz, DMSO-d₆): δ 1.09 (t, 3H, J = 6.9 Hz, CH₃), 1.15 (t, 3H, J = 6.9 Hz, CH₃), 3.50–3.53 (m, 4H, 2CH₂), 7.79 (d, 2H, J = 8.4 Hz, Ar–H), 7.86 (d, 2H, J = 8.4 Hz, Ar–H), 10.34 (s, 1H, NH, D₂O exchangeable), 12.69 (s, 1H, OH, D₂O exchangeable); ¹³C-NMR (125 MHz, DMSO-d₆): 13.01, 13.47, 42.01, 42.47, 119.50, 125.03, 130.73, 143.78, 163.87, 164.12, 167.51, 168.83. EIMS (m/z): 321.139 (M⁺); elemental analysis calcd. for C₁₄H₁₆ClN₅O₂: C, 52.26; H, 5.01; Cl, 11.02; N, 21.77. Found: C, 52.30; H, 5.05; Cl, 10.98; N, 21.80.

4-((4-chloro-6-morpholino-1,3,5-triazin-2-yl)amino)benzoic acid (12)

The product was obtained as white solid, 2.14 g (91.1%) yield; mp: 308–311 (dec.)  °C; IR (KBr): 3700–2500 (br, OH, acid), 3413(NH, amine), 1684 (CO, acid) cm⁻¹; ¹H-NMR (500 MHz, DMSO-d₆): δ 3.58–3.62 (m, 4H, 2CH₂), 3.65–3.69 (m, 4H, 2CH₂), 7.77–7.86 (m, 4H, Ar–H), 10.41 (s, 1H, NH, D₂O exchangeable), 12.61 (s, 1H, OH, D₂O exchangeable); ¹³C-NMR (125 MHz, DMSO-d₆): 43.91, 66.54, 119.02, 125.26, 130.81, 143.46, 164.50, 165.17, 167.49, 167.66. Elemental analysis calcd. for C₁₄H₁₄ClN₅O₃: C, 50.08; H, 4.20; Cl, 10.56; N, 20.86. Found: C, 50.17; H, 4.15; Cl, 10.51; N, 20.98.

4-((4-chloro-6-(piperidin-1-yl)-1,3,5-triazin-2-yl)amino)benzoic acid (13)

The product was obtained as white solid, 2.11 g (90.3%) yield; mp: 284–287 (dec.) ^oC; IR (KBr): 3700–2600 (br, OH, acid), 3269 (NH, amine), 1689 (CO, acid) cm⁻¹; ¹H-NMR (500 MHz, DMSO-d₆): δ 0.85–0.88 (m, 3H, pip), 1.51–1.54 (m, 2H, CH₂-pip), 3.18–3.24 (m, 3H, pip), 7.80–7.84 (m, 4H, Ar–H), 10.26–10.37 (m, 1H, NH, D₂O exchangeable), 12.72 (s, 1H, OH, D₂O exchangeable); ¹³C-NMR (125 MHz, DMSO-d₆): 11.92, 22.36, 42.96, 119.63, 125.05, 130.68, 143.80, 164.27, 165.91, 167.51, 168.43. Elemental analysis calcd. for C₁₅H₁₆ClN₅O₂:C, 53.98; H, 4.83; Cl, 10.62; N, 20.98. Found: C, 53.91; H, 4.89; Cl, 10.56; N, 21.03.

General procedure for the synthesis of 4-((4,6-disubstituted-1,3,5-triazin-2-yl)amino)benzoic acid derivatives (14-18)

Method A

Conventional procedure: To a solution of N-(4,6-dichloro-1,3,5-triazin-2-yl)aminobenzoic acid 3 (0.71 g, 2.5 mmol) and sodium carbonate (0.95 g, 9.0 mmol) in distilled water (20 mL), a solution of amine (6.25 mmol) in dioxane (5 mL) was added while stirring. The reaction mixture was stirred at room temperature for 2 h then refluxed at 70–80 °C for 8–10 h. The reaction mixture was neutralized with 1 N HCl after cooling. The corresponding crude products were filtered, dried, and recrystallized from ethanol.

Method B

Microwave-irradiation: Employing a multimode reactor (Synthos 3000, Aton Paar GmbH, 1400 W maximum magnetron), the initial step was conducted with 4-Teflon vessels rotor (MF 100) that allow processing four reactions under the same conditions. Each vessel has N-(4,6-dichloro-1,3,5-triazin-2-yl)aminobenzoic acid 3 (0.71 g, 2.5 mmol) and sodium carbonate (0.95 g, 9.0 mmol) mixed with the appropriate amine (6.25 mmol) in 3 mL dioxane/water (1:1). The individual vessels were purged with nitrogen gas for 5 min and then were placed in the corresponding rotor, fixed by screwing down the upper rotor place, and finally the rotor was closed with a protective hood. The vessels were heated for 5 min at 100 °C and held at the same temperature for a further 5 min (~2 bar pressure, 400 W). Cooling was accomplished by a fan (5 min). The reaction mixture was neutralized with 1 N HCl after cooling. The corresponding crude products were filtered, dried, and recrystallized from ethanol (Additional file 1).

4-((4,6-bis(phenylamino)-1,3,5-triazin-2-yl)amino)benzoic acid (14)

The product was obtained as white solid, Method A 0.75 g (75.3%) yield; Method B 0.91 g (91%) yield; mp: 318–320 °C; IR (KBr): 3600–2700 (br, OH, acid), 3413 (NH, amine), 1686 (CO, acid) cm⁻¹; ¹H-NMR (500 MHz, DMSO-d₆): δ 7.27–7.83 (m, 14H, Ar–H), 9.34–9.89 (m, 3H, NH, D₂O exchangeable), 12.53 (s, 1H, OH, D₂O exchangeable); ¹³C-NMR (125 MHz, DMSO-d₆): 119.48, 121.14, 122.83, 124.07, 128.94, 130.54, 140.27, 144.96, 164.52, 164.63, 167.76. Elemental analysis calcd. for C₂₂H₁₈N₆O₂: C, 66.32; H, 4.55; N, 21.09. Found: C, 66.12; H, 4.65; N, 21.01.

4-((4,6-bis(benzylamino)-1,3,5-triazin-2-yl)amino)benzoic acid (15)

The product was obtained as white solid, Method A 0.85 g (79.2%) yield; Method B 0.95 g (88.5%) yield; mp: 308–310 °C; IR (KBr): 3600–2800 (br, OH, acid), 3441 (NH, amine), 1677 (CO, acid) cm⁻¹; ¹H-NMR (500 MHz, DMSO-d₆): δ 4.42–4.49 (m, 4H, 2CH₂), 7.18–7.77 (m, 16H, 14 Ar–H, 2NH), 9.25–9.31 (m, 1H, NH, D₂O exchangeable), 11.97 (s, 1H, OH, D₂O exchangeable); ¹³C-NMR (125 MHz, DMSO-d₆): 43.93, 118.77, 127.03, 127.41, 127.62, 127.95, 128.71, 130.43. 141.07, 164.61, 166.18, 166.27, 167.95. EIMS (m/z): 426.055 (M⁺); elemental analysis calcd. for C₂₄H₂₂N₆O₂: C, 67.59; H, 5.20; N, 19.71. Found: C, 67.67; H, 5.12; N, 19.81.

4-((4,6-bis(diethylamino)-1,3,5-triazin-2-yl)amino)benzoic acid (16)

The product was obtained as white solid, Method A 0.77 g (85.9%) yield; Method B 0.82 g (92%) yield; mp: 280–283 °C; IR (KBr): 3700–2700 (br, OH, acid), 3420 (NH, amine), 1683 (CO, acid) cm⁻¹; ¹H-NMR (500 MHz, DMSO-d₆): δ 1.09 (des. t, 12H, 4CH₃), 3.50–3.61 (m, 8H, 4CH₂), 7.77–7.86 (m, 4H, Ar–H), 9.27 (s, 1H, NH, D₂O exchangeable), 12.48 (s, 1H, OH, D₂O exchangeable); ¹³C-NMR (125 MHz, DMSO-d₆): 13.77, 13.95, 41.22, 118.52, 119.13, 123.54, 145.84, 164.48, 167.67. EIMS (m/z): 358.144 (M⁺); elemental analysis calcd. for C₁₈H₂₆N₆O₂: C, 60.32; H, 7.31; N, 23.45. Found: C, 60.22; H, 7.40; N, 23.52.

4-((4,6-dimorpholino-1,3,5-triazin-2-yl)amino)benzoic acid (17)

The product was obtained as white solid, Method A 0.72 g (74.5%) yield; Method B 0.85 g (88%) yield; mp: 292–294 °C; IR (KBr): 3700–2500 (br, OH, acid), 3438 (NH, amine), 1711 (CO, acid) cm⁻¹; ¹H-NMR (500 MHz, DMSO-d₆): δ 3.60–3.69 (m, 16H, 8CH₂), 7.73 (d, 2H, J = 8.4 Hz, Ar–H), 7.83 (d, 2H, J = 8.4 Hz, Ar–H), 9.74–9.87 (m, 1H, NH, D₂O exchangeable). Elemental analysis calcd. for C₁₈H₂₂N₆O₄: C, 55.95; H, 5.74; N, 21.75. Found: C, 56.01; H, 5.63; N, 21.64.

3.1.3.5.4-((4,6-di(piperidin-1-yl)-1,3,5-triazin-2-yl)amino)benzoic acid (18)

The product was obtained as white solid, Method A 0.82 g (85.8%) yield; Method B 0.89 g (93.1%) yield; mp: 284–286 °C; IR (KBr): 3700–2500 (br, OH, acid), 3291 (NH, amine), 1691 (CO, acid) cm⁻¹; ¹H-NMR (500 MHz, DMSO-d₆): δ 0.84–0.87 (m, 6H, 3CH₂-pip), 1.49–1.51 (m, 4H, 2CH₂-pip), 3.18–3.20 (m, 10H, 5CH₂-pip), 7.77–7.90 (m, 4H, Ar–H), 9.15–9.55 (m, 1H, NH, D₂O exchangeable), 12.52 (brs, 1H, OH, D₂O exchangeable); ¹³C-NMR (125 MHz, DMSO-d₆): 11.94, 23.06, 42.31, 118.75, 123.16, 130.52, 145.73, 164.21, 165.89, 166.2, 167.84. Elemental analysis calcd. for C₂₀H₂₆N₆O₂: C, 62.81; H, 6.85; N, 21.97. Found: C, 62.73; H, 6.94; N, 22.02.

General procedure for the synthesis of 4-((4-substituted-6-morpholino-1,3,5-triazin-2-yl)amino)benzoic acid derivatives (19–22)

Method A

Conventional procedure: To a solution of N-(4-chloro-6-substituted-1,3,5-triazin-2-yl)aminobenzoic acid (2.5 mmol) and sodium carbonate (0.66 g, 6.25 mmol) in distilled water (15 mL), add a solution of morpholine (0.33 mL, 3.75 mmol) in dioxane (5 mL) with stirring. The reaction mixture was stirred at room temperature for 2 h then refluxed at 70–80 °C for 8–9 h. The reaction mixture was neutralized with 1 N HCl after cooling. The corresponding crude products were filtered, dried, and recrystallized from ethanol.

Method B

Microwave-irradiation: Employing a multimode reactor (Synthos 3000, Aton Paar GmbH, 1400 W maximum magnetron); the initial step was conducted with 4-Teflon vessels rotor (MF 100) that allow processing four reactions under the same conditions. Each vessel has N-(4-chloro-6-substituted-1,3,5-triazin-2-yl)aminobenzoic acid (2.5 mmol) and sodium carbonate (0.66 g, 6.25 mmol) mixed with morpholine (0.33 mL, 3.75 mmol) in 3 mL dioxane/water (1:1). The individual vessels were purged with nitrogen gas for 5 min and then were placed in the corresponding rotor, fixed by screwing down the upper rotor place, and finally the rotor was closed with a protective hood. The vessels were heated for 5 min at 100 °C and held at the same temperature for a further 5 min (~2 bar pressure, 400 W). Cooling was accomplished by a fan (5 min). The reaction mixture was neutralized with 1 N HCl after cooling. The corresponding crude products were filtered, dried, and recrystallized from ethanol.

4-((4-morpholino-6-(phenylamino)-1,3,5-triazin-2-yl)amino)benzoic acid (19)

The product was obtained as white solid, Method A 0.88 g (89.7%) yield; Method B 0.90 g (92%) yield; mp: 317–320 (dec.) °C; IR (KBr): 3750–2700 (br, OH, acid), 3410 (NH, amine), 1687 (CO, acid) cm⁻¹; ¹H-NMR (500 MHz, DMSO-d₆): δ 3.64 (des. t, 4H, 2CH₂–N), 3.73 (des. t, 4H, 2CH₂–O), 6.95–7.96 (m, 9H, Ar–H), 9.28–9.34 (m, 1H, NH, D₂O exchangeable), 9.55–9.59 (m, 1H, NH, D₂O exchangeable), 12.46 (s, 1H, OH, D₂O exchangeable); ¹³C-NMR (125 MHz, DMSO-d₆): 44.01, 66.52, 119.29, 121.02, 122.61,123.94, 128.96, 130.62, 140.40, 145.04, 164.54, 164.61, 165.22, 167.76. Elemental analysis calcd. for C₂₀H₂₀N₆O₃: C, 61.21; H, 5.14; N, 21.42. Found: C, 61.31; H, 5.04; N, 21.32.

4-((4-(benzylamino)-6-morpholino-1,3,5-triazin-2-yl)amino)benzoic acid (20)

The product was obtained as white solid, Method A 0.85 g (83.7%) yield; Method B 0.92 g (90.6%) yield; mp: 229–232 °C; IR (KBr): 3700–2600 (br, OH, acid), 3410 (NH, amine), 1687 (CO, acid) cm⁻¹; ¹H-NMR (500 MHz, DMSO-d₆): δ 3.57-3.74 (m, 8H, 4CH₂), 4.45–4.50 (m, 2H, benzyl CH₂), 7.18–7.71 (m, 4H, Ar–H), 7.69–7.85 (m, 5H, Ar–H), 9.49–9.73 (m, 1H, NH, D₂O exchangeable), 12.40 (s, 1H, OH, D₂O exchangeable); ¹³C-NMR (125 MHz, DMSO-d₆): 43.93, 44.09, 66.48, 119.00, 123.60, 127.18, 128.73, 130.56, 140.75, 145.12, 164.54, 164.61, 165.22, 167.66. Elemental analysis calcd. for C₂₁H₂₂N₆O₃: C, 62.06; H, 5.46; N, 20.68. Found: C, 62.17; H, 5.58; N, 20.48.

4-((4-(diethylamino)-6-morpholino-1,3,5-triazin-2-yl)amino)benzoic acid (21)

The product was obtained as white solid, Method A 0.78 g (83.8%) yield; Method B 0.84 g (90.2%) yield; mp: 258–261 °C; IR (KBr): 3700–2500 (br, OH, acid), 3391 (NH, amine), 1687 (CO, acid) cm⁻¹; ¹H-NMR (500 MHz, DMSO-d₆): δ 1.10 (des. t, 6H, 2 CH₃), 3.49–3.52 (m, 4H, 2CH₂), 3.58-3.73 (m, 8H, 4CH₂), 7.81 (m, 4H, Ar–H), 9.45 (m, 1H, NH, D₂O exchangeable), 12.52 (s, 1H, OH, D₂O exchangeable); ¹³C-NMR (125 MHz, DMSO-d₆): 13.60, 13.77, 41.38, 43.90, 66.52, 118.79, 123.46, 130.66, 145.35, 164.02, 164.69, 164.88, 167.68. Elemental analysis calcd. for C₁₈H₂₄N₆O₃: C, 58.05; H, 6.50; N, 22.57. Found: C, 58.00; H, 6.48; N, 22.52.

4-((4-morpholino-6-(piperidin-1-yl)-1,3,5-triazin-2-yl)amino)benzoic acid (22)

The product was obtained as white solid, Method A 0.79 g (82.2%) yield; Method B 0.88 g (91.6%) yield; mp: 248–250 °C; IR (KBr): 3700–2700 (br, OH, acid), 3292 (NH, amine), 1656 (CO, acid) cm⁻¹; ¹H-NMR (500 MHz, DMSO-d₆): δ 0.85–0.88 (m, 3H, pip), 1.50–1.51 (m, 2H, CH₂-pip), 3.21–3.68 (m, 13H, 4CH₂-mor, 5H-pip), 7.81–7.85 (m, 4H, Ar–H), 9.54–9.65 (m, 1H, NH, D₂O exchangeable), 12.41 (brs, 1H, OH, D₂O exchangeable); ¹³C-NMR (125 MHz, DMSO-d₆): 12.02, 23.01, 42.64, 44.01, 66.48, 119.09, 123.77, 130.62, 145.87, 164.48, 165.91, 167.65. Elemental analysis calcd. for C₁₉H₂₄N₆O₃: C, 59.36; H, 6.29; N, 21.86. Found: C, 59.31; H, 6.22; N, 21.75.

General procedure for the synthesis of methyl 4-((4,6-disubsituted-1,3,5-triazin-2-yl)amino)benzoic acid derivatives (23–31)

Concentrated sulphuric acid (0.5 mL, 99%) was added to a cooled suspension of N-(4,6-disubsituted-1,3,5-triazin-2-yl)aminobenzoic acid (1 mmol) in methanol (20 mL). The reaction mixture was refluxed for 8–10 h. The reaction mixture was cooled and poured into sodium bicarbonate solution. The corresponding crude products were filtered, dried, and recrystallized from ethanol (Additional file 1).

Methyl 4-((4,6-bis(phenylamino)-1,3,5-triazin-2-yl)amino)benzoate (23)

The product was obtained as white solid, 0.39 g (94.6%) yield; mp: 250–252 °C; IR (KBr): 3400 (NH, amine), 1705 (CO, ester) cm⁻¹; ¹H-NMR (500 MHz, DMSO-d₆): δ 3.80 (s, 3H, OCH₃), 7.27–7.85 (m, 14H, Ar–H), 9.37–9.95 (m, 3H, NH, D₂O exchangeable); ¹³C-NMR (125 MHz, DMSO-d₆): 52.35, 119.57, 121.16, 122.82, 128.96, 129.34, 130.41, 140.19, 145.35, 164.42, 164.52, 166.56. Elemental analysis calcd. for C₂₃H₂₀N₆O₂: C, 66.98; H, 4.89; N, 20.38. Found: C, 66.83; H, 4.77; N, 20.26.

Methyl 4-((4,6-bis(benzylamino)-1,3,5-triazin-2-yl)amino)benzoate (24)

The product was obtained as white solid, 0.44 g (99.8%) yield; mp: 272–274 °C; IR (KBr): 3413 (NH, amine), 1711 (CO, ester) cm⁻¹; ¹H-NMR (500 MHz, DMSO-d₆): δ 3.76 (s, 3H, OCH₃), 4.42–4.48 (m, 4H, 2CH₂), 7.18–7.69 (m, 16H, 14 Ar–H, 2NH), 9.30–9.36 (m, 1H, NH, D₂O exchangeable); ¹³C-NMR (125 MHz, DMSO-d₆): 43.93, 52.25, 118.87, 127.05, 127.34, 127.41, 127.62, 128.71, 130.31. 141.01, 166.60. Elemental analysis calcd. for C₂₅H₂₄N₆O₂: C, 68.17; H, 5.49; N, 19.08. Found: C, 68.05; H, 5.37; N, 19.01.

Methyl 4-((4,6-bis(diethylamino)-1,3,5-triazin-2-yl)amino)benzoate (25)

The product was obtained as white solid, 0.35 g (94.0%) yield; mp: 190–192 °C; IR (KBr): 3338 (NH, amine), 1718 (CO, ester) cm⁻¹; ¹H-NMR (500 MHz, DMSO-d₆): δ 1.10 (m, 12H, 4CH₃), 3.48–3.54 (m, 8H, 4CH₂), 3.76 (s, 3H, OCH₃), 7.79–7.88 (m, 4H, Ar–H), 9.33 (s, 1H, NH, D₂O exchangeable); ¹³C-NMR (125 MHz, DMSO-d₆): 13.77, 13.95, 41.24, 52.19, 118.60, 121.84, 130.41, 146.24, 164.46, 166.60. Elemental analysis calcd. for C₁₉H₂₈N₆O₂: C, 61.27; H, 7.58; N, 22.56. Found: C, 61.15; H, 7.46; N, 22.45.

Methyl 4-((4,6-dimorpholino-1,3,5-triazin-2-yl)amino)benzoate (26)

The product was obtained as white solid, 0.32 g (79.9%) yield; mp: 141–144 °C; IR (KBr): 3411 (NH, amine), 1711 (CO, ester) cm⁻¹; ¹H-NMR (500 MHz, DMSO-d₆): δ 3.60–3.68 (m, 16H, 8CH₂), 3.77 (s, 3H, OCH₃), 7.81–7.85 (m, 4H, Ar–H), 9.54 (s, 1H, NH, D₂O exchangeable); ¹³C-NMR (125 MHz, DMSO-d₆): 43.88, 52.27, 66.52, 119.08, 122.38, 130.58, 145.54, 164.50, 165.15, 166.63. Elemental analysis calcd. for C₁₉H₂₄N₆O₄: C, 56.99; H, 6.04; N, 20.99. Found: C, 56.87; H, 5.93; N, 20.88.

Methyl 4-((4,6-di(piperidin-1-yl)-1,3,5-triazin-2-yl)amino)benzoate (27)

The product was obtained as white solid, 0.35 g (88.3%) yield; mp: 240-242 °C; IR (KBr): 3335 (NH, amine), 1711 (CO, ester) cm⁻¹; ¹H-NMR (500 MHz, DMSO-d₆): δ 0.84–0.87 (m, 8H, 4CH₂), 1.48–1.50 (m, 4H, 2CH₂), 3.18–3.29 (m, 8H, 4CH₂), 3.77 (s, 3H, OCH₃), 7.77–7.93 (m, 4H, Ar–H), 9.14-9.37 (m, 1H, NH, D₂O exchangeable); ¹³C-NMR (125 MHz, DMSO-d₆): 11.98, 23.06, 42.29, 52.23, 118.75, 119.31, 130.35, 146.20, 164.46, 166.14, 166.65. Elemental analysis calcd. for C₂₁H₂₈N₆O₂: C, 63.62; H, 7.12; N, 21.20. Found: C, 63.53; H, 7.05; N, 21.09.

Methyl 4-((4-morpholino-6-(phenylamino)-1,3,5-triazin-2-yl)amino)benzoate (28)

The product was obtained as white solid, 0.28 g (69.0%) yield; mp: 232–234 °C; IR (KBr): 3404(NH, amine), 1709 (CO, ester) cm⁻¹; ¹H-NMR (500 MHz, DMSO-d₆): δ 3.64 (des. t, 4H, 2CH₂-N), 3.73 (des. t, 4H, 2CH₂-O), 3.77 (s, 3H, OCH₃), 6.95–7.96 (m, 9H, Ar–H), 9.29–9.35 (m, 1H, NH, D₂O exchangeable), 9.61–9.71 (m, 1H, NH, D₂O exchangeable); ¹³C-NMR (125 MHz, DMSO-d₆): 44.03, 52.31, 66.52, 119.34, 119.53, 120.77, 122.61, 128.96, 130.48, 140.39, 145.48, 164.52, 165.20, 166.59. Elemental analysis calcd. for C₂₁H₂₂N₆O₃: C, 62.06; H, 5.46; N, 20.68. Found: C, 61.97; H, 5.33; N, 20.57.

Methyl 4-((4-(benzylamino)-6-morpholino-1,3,5-triazin-2-yl)amino)benzoate (29)

The product was obtained as white solid, 0.34 g (80.9%) yield; mp: 155–158 °C; IR (KBr): 3340 (NH, amine), 1714 (CO, ester) cm⁻¹; ¹H-NMR (500 MHz, DMSO-d₆): δ 3.60–3.66 (m, 8H, 4CH₂), 3.77 (s, 3H, OCH₃), 4.45–4.50 (dd, 2H, J = 23.7, 6.1 Hz, benzyl CH₂), 7.17–7.30 (m, 4H, Ar–H), 7.63–7.88 (m, 5H, Ar–H), 9.42–9.47 (m, 1H, NH, D₂O exchangeable); ¹³C-NMR (125 MHz, DMSO-d₆): 43.84, 44.07, 52.25, 66.50, 79.63, 118.98, 122.24, 127.15, 127.34, 127.95, 128.71, 130.45, 140.88, 145.84, 164.57, 165.18, 166.48, 166.62. EIMS (m/z): 420.036 (M⁺); elemental analysis calcd. for C₂₂H₂₄N₆O₃: C, 62.84; H, 5.75; N, 19.99. Found: C, 62.76; H, 5.65; N, 19.87.

Methyl 4-((4-(diethylamino)-6-morpholino-1,3,5-triazin-2-yl)amino)benzoate (30)

The product was obtained as white solid, 0.28 g (72.5%) yield; mp: 151–153 °C; IR (KBr): 3337 (NH, amine), 1717 (CO, ester) cm⁻¹; ¹H-NMR (500 MHz, DMSO-d₆): δ 1.10 (des. t, 6H, 2 CH₃), 3.49–3.54 (m, 4H, 2CH₂), 3.59–3.68 (m, 8H, 4CH₂), 3.77 (s, 3H, OCH₃), 7.82–7.86 (m, 4H, Ar–H), 9.44 (s, 1H, NH, D₂O exchangeable); ¹³C-NMR (125 MHz, DMSO-d₆): 13.62, 13.77, 41.30, 43.86, 66.54, 79.70, 118.81, 122.11, 130.48, 145.92, 164.50, 165.22, 166.58. Elemental analysis calcd. for C₁₉H₂₆N₆O₃: C, 59.05; H, 6.78; N, 21.75. Found: C, 59.01; H, 6.67; N, 21.65.

Methyl 4-((4-morpholino-6-(piperidin-1-yl)-1,3,5-triazin-2-yl)amino)benzoate (31)

The product was obtained as white solid, 0.26 g (65.3%) yield; mp: 140–142 °C; IR (KBr): 3342 (NH, amine), 1714 (CO, ester) cm⁻¹; ¹H-NMR (500 MHz, DMSO-d₆): δ 1.47–1.59 (m, 6H, 3CH₂, pip), 3.54-3.69 (m, 12H, 4CH₂ mor, 2CH₂ pip), 3.77 (s, 3H, OCH₃), 7.80-7.82 (m, 4H, Ar–H), 9.46 (s, 1H, NH, D₂O exchangeable); ¹³C-NMR (125 MHz, DMSO-d₆): 24.86, 25.94, 43.91, 44.22, 52.23, 66.56, 118.94, 122.21, 130.54, 145.78, 164.57, 164.73, 165.36, 166.58. Elemental analysis calcd. for C₂₀H₂₆N₆O₃: C, 60.29; H, 6.58; N, 21.09. Found: C, 60.20; H, 6.49; N, 21.02.

Biology

The microdilution susceptibility test in Müller-Hinton Broth (Oxoid) and Sabouraud Liquid Medium (Oxoid) were used for the determination of antibacterial and antifungal activity [45]. The utilized test organisms were: Escherichia coli (E. coli) ATCC 25922 as an example of Gram-negative bacteria, Staphylococcus aureus (S. aureus) ATCC 19433 as an example of Gram-positive bacteria and Candida albicans (C. albicans) as yeast-like fungi. Ampicillin trihydrate and clotrimazole were used as standard antibacterial and antifungal agents, respectively. Solutions of the test compounds, ampicillin trihydrate and clotrimazole were prepared in DMSO to a concentration of 1600 μg/mL. Twofold dilutions of the compounds were prepared ($800,400,\dots 6.25$ μg/mL). Microorganism suspensions at 106 CFU/mL (Colony Forming Unit/mL) concentrations were inoculated to the corresponding wells. Plates were incubated at 36 °C for 24–48 h. The incubation chamber was kept sufficiently humid. At the end of the incubation period, the minimal inhibitory concentrations (MIC) were determined.

Invitro cytotoxicity of the test compounds (10) and (13) were carried out with 5ero cell line using Mosmann method with certain modifications as described in the literature [46]. Briefly the cells were incubated for 72 h with different dilutions of selected compounds using MTT as reagent for the detection of cytotoxicity. Results were expressed as half maximal cytotoxic concentration (CC₅₀) of the fibroblast cells in µg/mL. 50% cytotoxic concentration (CC₅₀) values represent the concentration of compound required to kill 50% of the fibroblast cells. The selectivity index (SI) was calculated using the formula, SI = CC₅₀/MIC.

Conclusions

Synthesis and characterization of mono-, di- and trisubstituted s-triazine derivatives, containing 4-aminobenzoic acid moiety were described. The 1,3,5-triazine tripod series were prepared by conventional method or by using microwave irradiation, employing a multimode reactor (Synthos 3000, Aton Paar GmbH, 1400 W maximum magnetron). Using microwave irradiation gave the desired products in less time, good yield and higher purity. Esterification of the 4-aminobenzoic acid moiety afforded methyl ester analogues. All synthesized compounds were evaluated for their antimicrobial activity. Where, some of which showed either comparable or 50% activity of that of ampicillin against S. aureus and E. coli. All compounds had lower antifungal activity than clotrimazole (Canesten^®, Bayer). Compounds (10), (16), (25) and (30) have antimicrobial activity against S. aureus comparable to that of ampicillin, while the activity of compound (13) is about 50% of that of ampicillin. Compounds (13) and (14) have antimicrobial activity against E. coli comparable to that of ampicillin, while the activity of compounds (9–12) and (15) is about 50% of that of ampicillin.

Furthermore, minimum inhibitory concentrations values for clinical isolates of compounds (10), (13), (14), (16), (25) and (30) were tested. Compounds (10) and (13) were more active against MRSA and E. coli than ampicillin. Invitro cytotoxicity results revealed that compounds (10) and (13) were nontoxic up to 250 µg/mL (with SI = 10) and 125 µg/mL (with SI = 5), respectively. These results prompted us to further pursue in SAR as our future plane.

Additional file

Additional file 1. Additional figures. ^{(4.9MB, pdf)}